Exubrion Therapeutics® Appoints Jennifer Kirk to Board of Directors; Names Her CEO
ALPHARETTA, GA, March 18, 2025. Exubrion Therapeutics, the pioneering company behind Synovetin OA®, an innovative injectable treatment that provides relief for dogs suffering from chronic osteoarthritis, announced today that Jennifer…